Why We Age: Your Cells Forget What They Are

On September 30th, 2026, Nature published a review proposing that aging is your cells slowly forgetting what they are. About 90% of the chemical marks that pile up on DNA with age land on the switches that keep a cell's other possible identities turned off. It's a big idea, and it's a review, not an experiment: it redraws the map of old data, and the data underneath is small (seven immune samples, skin from six people, eight mice, with the pattern then checked in blood studies of thousands). Two hosts take it apart. One reads the papers: Waddington's valleys, Gurdon's frogs, Yamanaka's four factors, Horvath's clock. The other argues the older theory, that aging is damage, and follows the money: a 2022 study of 16 mammal species, the naked mole-rat that doesn't fit, the Sinclair mice that start with a DNA break, and why four grand theories of aging have already come and gone. Their shared reading, offered as a reading and not a finding: identity loss may be where damage ends up, not its rival. One experiment would separate the two, and nobody has run it. Then what it means for you. Altos Labs launched with $3 billion and has no disclosed drug in human trials; NewLimit has raised $610 million; Sam Altman put $180 million into Retro. The first regulated human test of a cellular rewind reported early data from three glaucoma patients on October 8th. And the $300 biological-age test you can buy today runs on clocks that, in a 2022 study, disagreed with themselves by up to nine years on the same sample. Calorie restriction and omega-3 moved those clocks by weeks to months. The one question to ask before you buy, and what to watch instead of the headlines. Disclosure: eight of the Altos review's eleven authors work at Altos Labs; one of the Nature review's three authors is employed by Novartis. Both conflicts are declared in the papers and examined here, not insinuated. None of this is medical advice. As of October 12th, 2026. RELATED EPISODES AI and Dogs: The Technology That Could Give Your Dog More Years — the longevity-drug side of the same question, tested in dogs CHAPTERS 00:00 Your cells forget what they are 01:12 What actually came out 02:13 The 90% number 03:37 Why this isn't Sinclair's theory 04:19 Waddington's valleys 05:34 Identity is reversible 06:27 Horvath's clock 07:35 The damage camp 09:23 The contested experiment 10:29 Four theories, four letdowns 11:24 The mouse record 12:32 Closer than the headlines say 13:28 Where the wear and tear ends up 14:24 The counterweight 15:06 Follow the money 16:23 The track record 17:09 The first human test 18:48 The test you can buy 20:21 What to ask before you buy 21:42 Each host's bottom line SOURCES Nature review (Yücel, Molière, Gladyshev), Sept 30, 2026: https://doi.org/10.1038/s41586-026-10955-0 Cell review, Altos Labs (Lu, Tu, Izpisua Belmonte), May 2026: https://doi.org/10.1016/j.cell.2026.04.020 The 90% PRC2 figure (Moqri et al., 2024): https://pmc.ncbi.nlm.nih.gov/articles/PMC11250797/ Higgins-Chen et al., Nature Aging 2022 — clock replicate noise: https://doi.org/10.1038/s43587-022-00248-2 Life Biosciences ER-100 early readout, Oct 8, 2026: https://www.lifebiosciences.com/life-biosciences-announces-first-in-human-data-from-ongoing-phase-1-trial-evaluating-er-100-in-optic-neuropathies/ Yamanaka in TIME, Aug 20, 2026: https://time.com/collection/longevity-leaders/2026/shinya-yamanaka/ Izpisua Belmonte at ESGCT via GEN, Oct 2025: https://www.genengnews.com/insights/esgct-2025-altos-labs-scientific-founder-targets-mesenchymal-drift-in-efforts-to-combat-diseases-of-aging/ Timmons & Brenner critique + authors' reply (Cell, 2024): https://www.brennerlab.net/wp-content/uploads/2024/03/Timmons24.pdf